Related Experiment Video
Updated: Jul 16, 2026

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
Published on: May 17, 2018
Assessment of clinical relevant fatigue level in cancer
Yoon Jung Chang1, Jung Suk Lee, Chang Geol Lee
1Research Institute for National Cancer Control and Evaluation, National Cancer Center, Goyang, Gyeonggi, South Korea.
Goals Of Work:
Fatigue is highly prevalent in cancer and greatly inferences with daily life. The goal of this study was to identify the most informative score in the Brief Fatigue Inventory and to define cut points for "mild," "moderate," and "severe" fatigue based on their relevance to quality of life (QOL).
Patients And Methods:
We surveyed cancer patients at five hospitals in Korea with self-administrated questionnaires. The patients were older than 18 years, have a histological diagnosis of malignancy, gave informed consent to participate, and were able to understand the questionnaires. We analyzed 150 cancer patients who reported fatigue.
Main Result:
"Usual fatigue" was a sensitive and reliable indicator of fatigue severity and was defined as mild (1-3), moderate (4-7), or severe (8-10) because it had the strongest correlation with the functional interference, symptoms, depression, and QOL.
Conclusion:
These cutpoints might be useful in clinical evaluation of fatigue in cancer. Our findings suggest a simple technique for the rapid screening of fatigue and for evaluating its impact on the symptoms and daily functioning of cancer patients.
Related Concept Videos
Cancer Survival Analysis
Fatigue
Heart Failure VII: Nursing Interventions
Muscle Recovery and Fatigue
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Angina III: Clinical Manifestations and Assessment

